000 | 01641 a2200457 4500 | ||
---|---|---|---|
005 | 20250514233651.0 | ||
264 | 0 | _c20051104 | |
008 | 200511s 0 0 eng d | ||
022 | _a0090-8258 | ||
024 | 7 |
_a10.1016/j.ygyno.2005.05.023 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBerkenblit, Anna | |
245 | 0 | 0 |
_aA6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. _h[electronic resource] |
260 |
_bGynecologic oncology _cOct 2005 |
||
300 |
_a50-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGenital Neoplasms, Female _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aPeptide Fragments _xadministration & dosage |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xadministration & dosage |
700 | 1 | _aMatulonis, Ursula A | |
700 | 1 | _aKroener, Joan F | |
700 | 1 | _aDezube, Bruce J | |
700 | 1 | _aLam, Gil N | |
700 | 1 | _aCuasay, Luceli C | |
700 | 1 | _aBrĂ¼nner, Nils | |
700 | 1 | _aJones, Terence R | |
700 | 1 | _aSilverman, Michael H | |
700 | 1 | _aGold, Michael A | |
773 | 0 |
_tGynecologic oncology _gvol. 99 _gno. 1 _gp. 50-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2005.05.023 _zAvailable from publisher's website |
999 |
_c15678385 _d15678385 |